SETD1B and acute myeloid leukemia: SETD1B catalyzes H3K4me3 in vitro [32]; therefore, we performed ChIP-seq analysis for H3K4me3 using SETD1B-mutated AML cells to measure the effects of SETD1B disruption on H3K4me3 distribution.